Summary: University of Maryland health law professor Diane Hoffman joins us to discuss the human microbiome market, probiotics, and microbiota transplants. The science is fascinating but the regulatory system is confused and confusing. Professor Hoffman’s involvement in ELSI working groups researching these areas makes her the go-to source for ideas on the various options regulatory options (including by the FDA and FTC) and their potential impact on the growth of this new and rapidly evolving science.
